International bio-tech company Genmab is on a mission to improve the life of cancer patients, after becoming the second largest U.S. IPO ever by a bio-tech company. Genmab CEO Jan van de Winkel joins Yahoo Finance's Adam Shapiro and Julie Hyman to discuss.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,